Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8816 |
High Similarity |
NPD6234 |
Discontinued |
0.8562 |
High Similarity |
NPD4966 |
Approved |
0.8562 |
High Similarity |
NPD4967 |
Phase 2 |
0.8562 |
High Similarity |
NPD4965 |
Approved |
0.8428 |
Intermediate Similarity |
NPD7228 |
Approved |
0.8366 |
Intermediate Similarity |
NPD37 |
Approved |
0.8194 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.8169 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.8013 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7975 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7975 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7908 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7908 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7908 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7892 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7888 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7867 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7866 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7857 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7848 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7848 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7791 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7755 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7755 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.773 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7727 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7697 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7688 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7655 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7647 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7647 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7636 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7636 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7636 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7625 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7613 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7607 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7603 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7602 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7584 |
Intermediate Similarity |
NPD447 |
Suspended |
0.756 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7532 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7529 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7528 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7516 |
Intermediate Similarity |
NPD1512 |
Approved |
0.75 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7484 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7483 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7468 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7467 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7466 |
Intermediate Similarity |
NPD5647 |
Approved |
0.7456 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7451 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7451 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7451 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7451 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7451 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7445 |
Intermediate Similarity |
NPD228 |
Approved |
0.7431 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7419 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7417 |
Intermediate Similarity |
NPD6653 |
Approved |
0.7415 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7412 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7396 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7383 |
Intermediate Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.7378 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7363 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7362 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7333 |
Intermediate Similarity |
NPD919 |
Approved |
0.7329 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.731 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.731 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7308 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7301 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7288 |
Intermediate Similarity |
NPD7296 |
Approved |
0.7278 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7273 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7267 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7267 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7267 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.726 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7256 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7226 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7226 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7225 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7222 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7219 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7208 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7202 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7202 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7202 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7197 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7195 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7179 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7178 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7171 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7171 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7171 |
Intermediate Similarity |
NPD943 |
Approved |
0.7171 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7171 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7169 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7161 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7161 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7161 |
Intermediate Similarity |
NPD6100 |
Approved |
0.716 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7153 |
Intermediate Similarity |
NPD9268 |
Approved |
0.7153 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7152 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7134 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7134 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7133 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7125 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7125 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7123 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7123 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7115 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7108 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7103 |
Intermediate Similarity |
NPD17 |
Approved |
0.7097 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7097 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7095 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7092 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7089 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7089 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7079 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7078 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7063 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7059 |
Intermediate Similarity |
NPD826 |
Approved |
0.7059 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7059 |
Intermediate Similarity |
NPD825 |
Approved |
0.7051 |
Intermediate Similarity |
NPD2438 |
Suspended |
0.7051 |
Intermediate Similarity |
NPD9570 |
Approved |
0.7048 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7039 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7037 |
Intermediate Similarity |
NPD920 |
Approved |
0.7037 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7027 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7027 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7027 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7025 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.6994 |
Remote Similarity |
NPD3687 |
Approved |
0.6994 |
Remote Similarity |
NPD3686 |
Approved |
0.6993 |
Remote Similarity |
NPD4062 |
Phase 3 |
0.6986 |
Remote Similarity |
NPD1778 |
Approved |
0.6974 |
Remote Similarity |
NPD7095 |
Approved |
0.697 |
Remote Similarity |
NPD7411 |
Suspended |
0.6966 |
Remote Similarity |
NPD9545 |
Approved |
0.6964 |
Remote Similarity |
NPD3749 |
Approved |
0.6962 |
Remote Similarity |
NPD5958 |
Discontinued |
0.6959 |
Remote Similarity |
NPD2981 |
Phase 2 |
0.6954 |
Remote Similarity |
NPD3018 |
Phase 2 |
0.6954 |
Remote Similarity |
NPD2861 |
Phase 2 |
0.6948 |
Remote Similarity |
NPD2979 |
Phase 3 |
0.6943 |
Remote Similarity |
NPD2796 |
Approved |
0.6941 |
Remote Similarity |
NPD6959 |
Discontinued |
0.6937 |
Remote Similarity |
NPD2219 |
Phase 1 |
0.6933 |
Remote Similarity |
NPD2797 |
Approved |
0.6928 |
Remote Similarity |
NPD3764 |
Approved |
0.6928 |
Remote Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.6918 |
Remote Similarity |
NPD1243 |
Approved |
0.6914 |
Remote Similarity |
NPD3688 |
Clinical (unspecified phase) |
0.6914 |
Remote Similarity |
NPD5401 |
Approved |
0.6914 |
Remote Similarity |
NPD3146 |
Approved |
0.6914 |
Remote Similarity |
NPD642 |
Clinical (unspecified phase) |
0.6909 |
Remote Similarity |
NPD7028 |
Phase 2 |
0.6903 |
Remote Similarity |
NPD5124 |
Phase 1 |
0.6903 |
Remote Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.6901 |
Remote Similarity |
NPD7315 |
Approved |
0.6899 |
Remote Similarity |
NPD5763 |
Approved |
0.6899 |
Remote Similarity |
NPD5762 |
Approved |
0.6899 |
Remote Similarity |
NPD1375 |
Discontinued |
0.6897 |
Remote Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.6892 |
Remote Similarity |
NPD1535 |
Discovery |
0.6892 |
Remote Similarity |
NPD1281 |
Approved |
0.6887 |
Remote Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.6883 |
Remote Similarity |
NPD6663 |
Approved |
0.6879 |
Remote Similarity |
NPD2799 |
Discontinued |
0.6875 |
Remote Similarity |
NPD7827 |
Phase 1 |
0.6872 |
Remote Similarity |
NPD8434 |
Phase 2 |
0.6867 |
Remote Similarity |
NPD6385 |
Approved |
0.6867 |
Remote Similarity |
NPD6386 |
Approved |
0.6855 |
Remote Similarity |
NPD4534 |
Discontinued |
0.6849 |
Remote Similarity |
NPD1548 |
Phase 1 |
0.6846 |
Remote Similarity |
NPD1481 |
Phase 2 |
0.6846 |
Remote Similarity |
NPD9717 |
Approved |
0.6845 |
Remote Similarity |
NPD5006 |
Approved |
0.6845 |
Remote Similarity |
NPD5005 |
Approved |
0.6839 |
Remote Similarity |
NPD3751 |
Discontinued |
0.6832 |
Remote Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.6821 |
Remote Similarity |
NPD6362 |
Approved |
0.6821 |
Remote Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.6818 |
Remote Similarity |
NPD3268 |
Approved |
0.6818 |
Remote Similarity |
NPD1296 |
Phase 2 |
0.6815 |
Remote Similarity |
NPD7097 |
Phase 1 |
0.6815 |
Remote Similarity |
NPD6111 |
Discontinued |
0.6813
|
Remote Similarity |
NPD6674 |
Discontinued |